Marked elevation of alkaline phosphatase in an infant treated with levetiracetam: A case report
Epilepsy & Behavior Reports · 2026-12 · 36 · 100896
DOI: 10.1016/j.ebr.2026.100896 ↗Kurz gefasst
Fallbericht in der Zeitschrift Epilepsy & Behavior Reports, 2026-12. Verfasst von Kim Dao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Levetiracetam (LEV) is widely used in the treatment of pediatric epilepsy and is typically well tolerated. We hereby present a case involving an infant who exhibited a notable and isolated elevation of alkaline phosphatase (ALP) during a treatment of LEV, with subsequent normalization following drug cessation. Liver function tests and bone turnover markers remained within normal limits, and the patient was asymptomatic. ALP levels returned to normal within four weeks of discontinuing LEV. LEV may cause significant, reversible ALP elevation in children, most likely due to bone origin. Although rare, this potential adverse effect should be considered, particularly during long-term therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Unit of Paediatric Neurology and Neurorehabilitation, Department Mother-Woman-Child, Lausanne University Hospital, and University of Lausanne, Lausanne, Switzerland.
- Division of Pediatric Nephrology, Department Mother-Woman-Child, Lausanne University Hospital, and University of Lausanne, Lausanne, Switzerland.
Zitieren
APA
Dao, K., Bonègre, E., Chehade, H., & Lebon, S. (2026). Marked elevation of alkaline phosphatase in an infant treated with levetiracetam: A case report. Epilepsy & Behavior Reports, 36, 100896. https://doi.org/10.1016/j.ebr.2026.100896
Vancouver
Dao K, Bonègre E, Chehade H, Lebon S. Marked elevation of alkaline phosphatase in an infant treated with levetiracetam: A case report. Epilepsy & Behavior Reports. 2026;36:100896. doi:10.1016/j.ebr.2026.100896
BibTeX
@article{Dao2026,
author = {Dao, Kim and Bonègre, Emmannuella and Chehade, Hassib and Lebon, Sébastien},
title = {Marked elevation of alkaline phosphatase in an infant treated with levetiracetam: A case report},
journal = {Epilepsy & Behavior Reports},
year = {2026},
volume = {36},
pages = {100896},
doi = {10.1016/j.ebr.2026.100896}
}
EUVIMED